REQUEST A DEMO
Total
USD $0.00
Search more companies

Youngjin Pharm. Ind. Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Youngjin Pharm. Ind. Co.,Ltd. Profile Updated: July 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Youngjin Pharm. Ind. Co.,Ltd. is engaged in manufacturing, supply and distribution of pharmaceutical products. The company offers antibiotics, CNS, cardiovascular (CV), endocrine system, respiratory, anti-inflammatory and analgesic, antihistamine, antifungal, total nutrition products, urinary system, vitamins and supplements, cosmetics, tonic drinks, among others. Youngjin Pharm. Ind. Co.,Ltd. offers its products in tablet, capsule, dried syrup (oral solution), suspension, medicine for external use, injectibles and infusions. The company is based in Seoul, South Korea. Youngjin Pharm. Ind. Co.,Ltd. was incorporated in 1962.

Headquarters
451-20 Cheonho 3-Dong, Kangdong-Gu
Seoul; Seoul; Postal Code: 134-020

Contact Details: Purchase the Youngjin Pharm. Ind. Co.,Ltd. report to view the information.

Website: http://www.yungjin.co.kr

Basic Information
Total Employees:
Purchase the Youngjin Pharm. Ind. Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Youngjin Pharm. Ind. Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Youngjin Pharm. Ind. Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Youngjin Pharm. Ind. Co.,Ltd. report to view the information.
Incorporation Date:
July 16, 1962
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
53%
Purchase this report to view the information.
0.11%
Purchase this report to view the information.
0.06%
Purchase this report to view the information.
0.06%
Company Performance
Financial values in the chart are available after Youngjin Pharm. Ind. Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
7.57%
Total operating revenue
7.61%
Operating profit (EBIT)
89.09%
EBITDA
2755.25%
Net Profit (Loss) for the Period
82.35%
Total assets
11.58%
Total equity
-0.26%
Operating Profit Margin (ROS)
3.03%
Net Profit Margin
8.41%
Return on Equity (ROE)
20.12%
Debt to Equity Ratio
36.14%
Quick Ratio
-0.22%
Cash Ratio
0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?